Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Immersion Faces Nasdaq Compliance Challenge Over Delayed Filing

Andreas Sommer by Andreas Sommer
September 4, 2025
in Earnings, Nasdaq, Tech & Software
0
Immersion Stock
0
SHARES
203
VIEWS
Share on FacebookShare on Twitter

Shares of Immersion Corporation came under scrutiny after the haptics technology specialist received a formal notification from the Nasdaq stock market regarding a compliance issue. The alert, issued on August 20, 2025, stems from the company’s failure to timely file its Annual Report on Form 10-K for the fiscal year that concluded on April 30, 2025.

The delay is directly connected to an ongoing internal investigation being conducted by the audit committee of Barnes & Noble Education (BNED), a subsidiary of Immersion. This development has introduced significant uncertainty for investors, prompting heightened attention to the company’s regulatory compliance efforts.

Key Details of the Notification:
* Notification Date: August 20, 2025
* Nature of Breach: Late submission of the Form 10-K annual report
* Root Cause: Internal probe at subsidiary Barnes & Noble Education (BNED)
* Response Deadline: 60 calendar days to submit a plan to regain compliance

Should investors sell immediately? Or is it worth buying Immersion?

In response to the notification, Immersion now has a 60-day window to present a detailed plan to Nasdaq outlining its path to rectifying this filing delinquency. A failure to satisfy the exchange’s requirements could lead to further disciplinary actions, including the potential for the stock’s delisting.

Reflecting the cautious market sentiment, Immersion’s stock closed its latest session at $7.01. The immediate focus for the company is squarely on resolving the filing delay and navigating the complexities of the internal investigation at BNED.

Despite these recent regulatory headwinds, some market analysts maintain a measured outlook on the stock’s potential. The current average price target among covering analysts stands at $12.25. This figure suggests a substantial upside potential of over 75% from the recent closing price of $6.99. While the average broker recommendation has softened from 1.50 to 2.00, it continues to signal an overall positive assessment of the company’s long-term value.

Ad

Immersion Stock: Buy or Sell?! New Immersion Analysis from February 7 delivers the answer:

The latest Immersion figures speak for themselves: Urgent action needed for Immersion investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Immersion: Buy or sell? Read more here...

Tags: Immersion
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

February 7, 2026
Universal Insurance Stock
Analysis

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock
Earnings

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Next Post
G1 Therapeutics Stock

G1 Therapeutics Acquisition Finalized in Landmark $405M Deal

Monopar Therapeutics Stock

Monopar Therapeutics Stock Surges on Clinical Progress and Analyst Optimism

Voyager Therapeutics Stock

Voyager Therapeutics Stock Gains Momentum Following Investor Conference Appearances

Recommended

XRP Stock

XRP Faces Resistance as Rally Attempt Falters

2 months ago
Insurance company Stock Bull Market

Analyst Expresses Optimism Towards Travelers Companies and Allstate

2 years ago
Rheinmetall Stock

German Defense Giant Rheinmetall Poised for Major Air Defense Contract

4 months ago
Finance_Capitalistic

Top Stock Picks and Performance Analysis on CNBCs Halftime Report Final Trades

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Camping World’s New Leadership Faces First Major Test

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Trending

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

by SiterGedge
February 7, 2026
0

With no recent corporate announcements influencing its share price, market attention has shifted decisively to the upcoming...

Universal Insurance Stock

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Investors Await March Report for Boston Omaha’s Strategic Direction
  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com